Nanosphere (NSPH) Reports Good News

Nanosphere (NSPH) might end 3Q'13 on a positive note after the company issued a press release this morning (02013.09.30) having the following title: "Study Demonstrates Significant Clinical and Economic Impact of Nanosphere's Verigene Blood Culture Test... Average per Patient Hospital Cost Savings of $60,000 and 22 Day Reduction in Length of Stay Observed"

On 02013.09.14 (two weeks ago) I had a Stocks::Stuffer posting titled: "Nanosphere (NSPH) Tanks Again".

NSPH closed last week (02013.09.27) at $2.07. 52-week range: $1.72 - $4.49.

[02013.09.30] Never mind. NSPH is down ~4.4% just a couple of minutes into trading. Today has gotten off to a dark red start.